GoogleAnalytics
Go
View All
FIGURE NET JEJUNUM and ILEUM-ANATOMY
FIGURE NET JEJUNUM and ILEUM-N2
FIGURE NET JEJUNUM and ILEUM-SURVIVAL, PATHOLOGICAL
FIGURE NET JEJUNUM and ILEUM-T2
FIGURE NET JEJUNUM and ILEUM-T4
FIGURE NET PANCREAS-N1
FIGURE NET PANCREAS-SURVIVAL, PATHOLOGICAL
FIGURE NET PANCREAS-T3
FIGURE NET STOMACH-ANATOMY
FIGURE NET STOMACH-NODAL MAP
FIGURE NET STOMACH-T1
FIGURE NET STOMACH-T3
Five-year overall survival of 2,013 patients with MCC in the NCDB with clinical staging only for local disease (cN0 pNx; i
Five-year overall survival of 5,371 patients with MCC in the NCDB with pathological staging, including 1,502 patients in stage group I, 493 in stage group IIA, 127 in stage group IIB, 1,536 in stage group IIIA, 929 in stage group IIIB, and 784 in stage group IV
Five-year overall survival of 9,387 patients with MCC in the NCDB, stratified by local, regional nodal, and distant metastatic disease
Fludarabine
Fluorouracil (5-Fu)
Focal seizures
For appendicular skeleton, trunk, skull, and facial bones, T2 is defined as tumor more than 8 cm in greatest dimension
For carcinomas T1a is tumor limited to the endometrium or invading less than half the myometrium
For carcinomas T2 is tumor invading the stromal connective tissue of the cervix but not extending beyond the uterus
For carcinomas T4 is tumor invading the bladder mucosa and/or bowel mucosa (bullous edema is not sufficient to classify a tumor as T4)
For appendicular skeleton, trunk, skull, and facial bones, T3 is defined as discontinuous tumors in the primary bone site
For carcinomas T1b is tumor invading one half or more of the myometrium
For carcinomas T3a is tumor involving the serosa and/or adnexa (direct extension or metastasis)
Free fatty acid (FFA)
French-American-British (FAB) system.
Fuhrman grading system
Refresh
firstprev
123
30select
nextlast
Displaying items 61 - 89 of 89